Ticagrelor-acetylsalicylic acid may reduce stroke risk furth

Ticagrelor-acetylsalicylic acid may reduce stroke risk further for obese patients than clopidogrel

1. For obese patients with minor stroke or transient ischemic attacks (TIA), subsequent therapy with ticagrelor-acetylsalicylic acid (ASA) was associated with lower risk of subsequent stroke compared to clopidogrel-ASA. 2. This difference in risk reduction was not observed in nonobese patients. Evidence Rating Level: 1 (Excellent) The treatment of patients with minor ischemic stroke and

Related Keywords

, Rating Level , High Risk Patients , Acute Nondisabling Cerebrovascular Events , Cardiology , Adapt , Neurology , Stroke , Thrombosis , Chronic Disease , Hematology ,

© 2025 Vimarsana